论文部分内容阅读
中华医学会内分泌学分会和中国药学会医院药学专业委员会发起组织了基于肠促胰素的药物治疗临床应用快速建议指南项目组,在母义明教授和北京大学第三医院翟所迪教授等的指导下,项目组专家根据2015年《世界卫生组织指南制定手册》,收集119份针对临床医务工作者和患者的调查问卷,确定指南着重关注的临床问题及结局指标,形成非常具临床实践意义、并能较好体现患者价值观及偏好的推荐意见。在2015年中华医学会糖尿病学分会年会上,母义明教授专门对该指南做了介绍。该快速建议指南的一大特点就是用非常简明直接的形式来回答临床医生和患者最为关心的问题。据悉,该指南将于2017-2018年进行更新。
The Chinese Society of Endocrinology Branch and the Chinese Pharmaceutical Association Hospital Pharmacy Committee sponsored the rapid development of clinical recommendations based on incretin-based drug treatment project guidelines, Professor Yu Yiming and Peking University Third Hospital Professor Zhai Suodi and so on Under the guidance of the project team experts, according to the WHO Handbook for the Development of 2015, a total of 119 questionnaires were collected for clinical medical workers and patients, and the clinical problems and outcome indicators that the guidelines focused on were set to have very clinical significance. And better reflect the values and preferences of patients recommended. At the annual meeting of Diabetes Branch of Chinese Medical Association in 2015, Professor Yoshinori specifically introduced the guide. One of the hallmarks of this quick advice guide is to answer the top concerns of clinicians and patients in a very concise and straightforward manner. It is reported that the guide will be updated in 2017-2018.